LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 42.81 27.76 258 3596 0.0717 0.3740
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 42.81 27.76 2362 3596 0.6568 0.8837
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 44.52 27.76 114 3884 0.0293 0.2192
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 44.52 27.76 2039 3884 0.5249 0.8271
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 44.52 27.76 1690 3884 0.4351 0.7796
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 44.52 27.76 1831 3884 0.4714 0.7998
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 44.52 27.76 300 3884 0.0772 0.3964
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 44.52 27.76 2528 3884 0.6508 0.8831
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 46.22 27.76 123 4125 0.0298 0.2291
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 46.22 27.76 2112 4125 0.5120 0.8228
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 46.22 27.76 1603 4125 0.3886 0.7544
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 46.22 27.76 1917 4125 0.4647 0.7985
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 46.22 27.76 330 4125 0.0800 0.4093
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 46.22 27.76 2656 4125 0.6439 0.8816
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 47.93 27.76 145 4421 0.0328 0.2536
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 47.93 27.76 2266 4421 0.5125 0.8254
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 47.93 27.76 1679 4421 0.3797 0.7521
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 47.93 27.76 1988 4421 0.4496 0.7930
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 47.93 27.76 355 4421 0.0803 0.4168
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 47.93 27.76 2785 4421 0.6299 0.8775
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 49.63 27.76 158 4818 0.0328 0.2633
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 49.63 27.76 2384 4818 0.4948 0.8195
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 49.63 27.76 1837 4818 0.3813 0.7569
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 49.63 27.76 2087 4818 0.4332 0.7873
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 49.63 27.76 349 4818 0.0724 0.4054
MN20160318_Q01
I21